Literature DB >> 23633966

American Society of Clinical Oncology National Census of Oncology Practices: preliminary report.

Gaetano J Forte1, Amy Hanley, Karen Hagerty, Anupama Kurup, Michael N Neuss, Therese M Mulvey.   

Abstract

In response to reports of increasing financial and administrative burdens on oncology practices and a lack of systematic information related to these issues, American Society of Clinical Oncology (ASCO) leadership started an effort to collect key practice-level data from all oncology practices in the United States. The result of the effort is the ASCO National Census of Oncology Practices (Census) launched in June 2012. The initial Census work involved compiling an inventory of oncology practices from existing lists of oncology physicians in the United States. A comprehensive, online data collection instrument was developed, which covered a number of areas, including practice characteristics (staffing configuration, organizational structure, patient mix and volume, types of services offered); organizational, staffing, and service changes over the past 12 months; and an assessment of the likelihood that the practice would experience organizational, staffing, and service changes in the next 12 months. More than 600 practices participated in the Census by providing information. In this article, we present preliminary highlights from the data gathered to date. We found that practice size was related to having experienced practice mergers, hiring additional staff, and increasing staff pay in the past 12 months, that geographic location was related to having experienced hiring additional staff, and that practices in metropolitan areas were more likely to have experienced practice mergers in the past 12 months than those in nonmetropolitan areas. We also found that practice size and geographic location were related to higher likelihoods of anticipating practice mergers, sales, and purchases in the future.

Entities:  

Mesh:

Year:  2013        PMID: 23633966      PMCID: PMC3545668          DOI: 10.1200/JOP.2012.000826

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  1 in total

1.  Future supply and demand for oncologists : challenges to assuring access to oncology services.

Authors:  Clese Erikson; Edward Salsberg; Gaetano Forte; Suanna Bruinooge; Michael Goldstein
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840

  1 in total
  6 in total

Review 1.  ASCO's approach to a learning health care system in oncology.

Authors:  George W Sledge; Clifford A Hudis; Sandra M Swain; Peter M Yu; Joshua T Mann; Robert S Hauser; Allen S Lichter
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

2.  Potential and challenges of patient-generated health data for high-quality cancer care.

Authors:  Arlene E Chung; Ethan M Basch
Journal:  J Oncol Pract       Date:  2015-04-07       Impact factor: 3.840

3.  Problems with public reporting of cancer quality outcomes data.

Authors:  Paul Goldberg; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

4.  Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer.

Authors:  Thomas A Abrams; Gary Meyer; Jeffrey A Meyerhardt; Brian M Wolpin; Deborah Schrag; Charles S Fuchs
Journal:  Oncologist       Date:  2017-05-05

5.  Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.

Authors:  Anna G Sorace; Chengyue Wu; Stephanie L Barnes; Angela M Jarrett; Sarah Avery; Debra Patt; Boone Goodgame; Jeffery J Luci; Hakmook Kang; Richard G Abramson; Thomas E Yankeelov; John Virostko
Journal:  J Magn Reson Imaging       Date:  2018-03-23       Impact factor: 4.813

6.  Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting.

Authors:  John Virostko; Anna G Sorace; Kalina P Slavkova; Anum S Kazerouni; Angela M Jarrett; Julie C DiCarlo; Stefanie Woodard; Sarah Avery; Boone Goodgame; Debra Patt; Thomas E Yankeelov
Journal:  Breast Cancer Res       Date:  2021-11-27       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.